It's no secret that compensation for physicians consulting at pharmaceutical, device and life sciences firms is often much higher than what's on the table at hospitals and university-affiliated medical centers.…

Board member Sylvie Veilleux (Salesforce, Dropbox), CFO Karen Moran (Alteryx, Domo) and CDO Mayur Thakur (Goldman Sachs, Google) bring decades of experience and add bench strength as H1 expands.…

In a post-COVID world, we're seeing a decade's worth of reshaping within clinical trials solidify in less than a year. While the life sciences industry was making a slow…

It matters because inclusion and trust matter. When developing therapies and medications, pharmaceutical and life sciences companies are tasked with designing products for a diverse range of patients and…

During drug development, life science companies often turn to healthcare professionals (HCPs) for input, advice and expertise. These HCPs advising companies are generally known as Key Opinion Leaders (KOLs), thought…

The best diagnostic journey for a patient is the shortest. The less time is lost between a patient seeing a healthcare provider for the first time for their symptoms…

Listening to webinars and reading reports about the latest trends and developments in medical affairs is one of the things we do incessantly at H1 – after all we need…

How can we break through the noise to reach healthcare providers and key opinion leaders with important information? Consistently engaging external experts has always been one of the main…

Even before COVID threw the entire healthcare ecosystem into disarray, payers as well as the healthcare market in general faced significant cost pressure. Healthcare payers reacted with consolidation and vertical…

In a recent interview an experienced medical affairs professional reminisced about the days when key opinion leader selection was a difficult and time consuming activity, which often relied on established…